Search

Author/Creator Bhundia, Vina

1. Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial. Issue 3 (March 2022)

Authors:
Fennell, Dean A; King, Amy; Mohammed, Seid; Greystoke, Alastair; Anthony, Sarah; Poile, Charlotte; Nusrat, Nada; Scotland, Molly; Bhundia, Vina; Branson, Amy; Brookes, Cassandra; Darlison, Liz; Dawson, Alan G; Gaba, Aarti; Hutka, Margaret; Morgan, Bruno; Bajaj, Amrita; Richards, Cathy; Wells-Jord...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 3(2022)
Page Start:
374
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial. Issue 6 (June 2021)

Authors:
Fennell, Dean A; King, Amy; Mohammed, Seid; Branson, Amy; Brookes, Cassandra; Darlison, Liz; Dawson, Alan G; Gaba, Aarti; Hutka, Margaret; Morgan, Bruno; Nicholson, Adrian; Richards, Cathy; Wells-Jordan, Peter; Murphy, Gavin James; Thomas, Anne; Fennell, Dean Anthony; King, Amy; Mohammed, Seid; B...
Journal:
Lancet
Issue:
Volume 9:Issue 6(2021)
Page Start:
593
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search